These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23954894)

  • 1. Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function.
    Coelho V; Krysov S; Steele A; Sanchez Hidalgo M; Johnson PW; Chana PS; Packham G; Stevenson FK; Forconi F
    Blood; 2013 Oct; 122(15):2664-72. PubMed ID: 23954894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients.
    Drennan S; Chiodin G; D'Avola A; Tracy I; Johnson PW; Trentin L; Steele AJ; Packham G; Stevenson FK; Forconi F
    Clin Cancer Res; 2019 Apr; 25(8):2503-2512. PubMed ID: 30373751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL.
    Chiodin G; Drennan S; Martino EA; Ondrisova L; Henderson I; Del Rio L; Tracy I; D'Avola A; Parker H; Bonfiglio S; Scarfò L; Sutton LA; Strefford JC; Forster J; Brake O; Potter KN; Sale B; Lanham S; Mraz M; Ghia P; Stevenson FK; Forconi F
    Blood Adv; 2022 Sep; 6(18):5494-5504. PubMed ID: 35640238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
    Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
    Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.
    Krysov S; Steele AJ; Coelho V; Linley A; Sanchez Hidalgo M; Carter M; Potter KN; Kennedy B; Duncombe AS; Ashton-Key M; Forconi F; Stevenson FK; Packham G
    Blood; 2014 Nov; 124(20):3101-9. PubMed ID: 25170122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells.
    Linley A; Krysov S; Ponzoni M; Johnson PW; Packham G; Stevenson FK
    Blood; 2015 Oct; 126(16):1902-10. PubMed ID: 26194765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.
    Nédellec S; Renaudineau Y; Bordron A; Berthou C; Porakishvili N; Lydyard PM; Pers JO; Youinou P
    J Immunol; 2005 Mar; 174(6):3749-56. PubMed ID: 15749915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
    Palomba ML; Piersanti K; Ziegler CG; Decker H; Cotari JW; Bantilan K; Rijo I; Gardner JR; Heaney M; Bemis D; Balderas R; Malek SN; Seymour E; Zelenetz AD; van den Brink MR; Altan-Bonnet G
    PLoS One; 2014; 9(1):e79987. PubMed ID: 24489640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4 enhances expression and function of surface IgM in CLL cells.
    Aguilar-Hernandez MM; Blunt MD; Dobson R; Yeomans A; Thirdborough S; Larrayoz M; Smith LD; Linley A; Strefford JC; Davies A; Johnson PM; Savelyeva N; Cragg MS; Forconi F; Packham G; Stevenson FK; Steele AJ
    Blood; 2016 Jun; 127(24):3015-25. PubMed ID: 27002119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo.
    Krysov S; Potter KN; Mockridge CI; Coelho V; Wheatley I; Packham G; Stevenson FK
    Blood; 2010 May; 115(21):4198-205. PubMed ID: 20237321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia.
    Chen SS; Chang BY; Chang S; Tong T; Ham S; Sherry B; Burger JA; Rai KR; Chiorazzi N
    Leukemia; 2016 Apr; 30(4):833-43. PubMed ID: 26582643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
    Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
    Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
    Stevenson FK; Forconi F; Packham G
    Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.
    Mockridge CI; Potter KN; Wheatley I; Neville LA; Packham G; Stevenson FK
    Blood; 2007 May; 109(10):4424-31. PubMed ID: 17255355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells.
    Krysov S; Dias S; Paterson A; Mockridge CI; Potter KN; Smith KA; Ashton-Key M; Stevenson FK; Packham G
    Blood; 2012 Jan; 119(1):170-9. PubMed ID: 22086413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
    Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
    Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.
    D'Avola A; Drennan S; Tracy I; Henderson I; Chiecchio L; Larrayoz M; Rose-Zerilli M; Strefford J; Plass C; Johnson PW; Steele AJ; Packham G; Stevenson FK; Oakes CC; Forconi F
    Blood; 2016 Aug; 128(6):816-26. PubMed ID: 27301861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
    Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
    Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.